AppLovin (NASDAQ: APP) stock is trading at about $450 while the average analyst price target sits at $648.57, implying over 45% upside from current levels. The disconnect is striking given that the fundamentals remain strong. By most measures, AppLovin’s business has never been stronger. AppLovin’s… Read More »Why Analysts Love AppLovin Stock But The Market Doesn’t
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing. My tenure at these premier Wall Street firms exposed me to fundamental analysis, credit evaluation, and risk management practices that directly translate… Read More »20 Years On Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out Of Style
The wars in Ukraine and Iran have thrust unmanned aircraft systems into the spotlight as essential tools for advancing military objectives. From precision strikes to real-time intelligence gathering, drones have proven decisive on the battlefield, reshaping tactics and strategies worldwide. Experts predict drones will form… Read More »The $10 Drone Stock That Won’t Be This Cheap For Very Long
Hedge funds and institutional investors have been quietly building positions in Meta Platforms (NASDAQ:META) despite recent market volatility, viewing it as one of the most compelling opportunities in the AI and digital advertising space. This institutional accumulation highlights the growing consensus that Meta offers asymmetric… Read More »Billionaires Are Loading Up On This Stock That Wall Street Says Has 31% Upside
When quality stocks go on sale, it can be an excellent time to buy, particularly for investors who are planning to hang on for the long term. While you shouldn’t necessarily try to time the market, it can be a good idea to keep a… Read More »Microsoft’s Stock Is Off To Its Worst Start To A Year Since 2008. Time To Buy?
Goldman Sachs is the acknowledged leader in the investment landscape on Wall Street and worldwide. The firm’s top-notch research department continues to provide institutional and high-net-worth clients with the best ideas across the investment spectrum and is likely to do so for years to come.… Read More »Goldman Sachs Says Hedge Funds And Mutual Funds Both Love 5 Top Stocks
Energy stocks have been strong over the last six months. With the United States’ attack on Iran, an escalation in pricing for oil is a given. However, the companies we are focusing on have strong cash flows, rising dividends, and continued share buybacks, and are… Read More »Iran Attack Will Launch Energy Stocks – 5 Strong Buy High-Yield Companies You Have To Own
Last week, Nvidia (NASDAQ:NVDA) and Meta Platforms (NASDAQ:META) expanded their partnership, with Meta committing to millions of Nvidia GPUs for its AI data centers. The news sent Advanced Micro Devices (NASDAQ:AMD) stock tumbling about 3%, as some analysts speculated it could signal the end of… Read More »Advanced Micro Devices Wrecks The Doomsayers With Massive Meta Pact
Apple (NASDAQ:AAPL) and Microsoft (NASDAQ:MSFT) are two of the largest companies, but it’s actually Google’s parent company, Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL), that has recently emerged as the most profitable company. Both companies have high profit margins, but Alphabet has more growth opportunities that can translate into… Read More »Meet The Most Profitable Company In America (It’s Not Apple Or Microsoft)
Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry significant risk, but their late-stage pipelines and upcoming catalysts have convinced institutional investors to build substantial positions.… Read More »Wall Street Thinks These 4 Biotech Stocks Will Double–At Least–This Year